The global in vivo CRO market has witnessed tremendous growth in recent years. In vivo CRO refers to contract research organizations that provide animal testing and research services to pharmaceutical, biotechnology, medical device, chemical, agricultural, and academic institutions. In vivo CROs help researchers safely evaluate the efficacy and adverse effects of new drugs, vaccines, medical devices, and chemicals through preclinical experiments using live animal models. The services offered by in vivo CROs include disease modeling, pharmacology studies, toxicology assessment, and other biology services.This helps companies to understand how new products may impact humans before clinical testing.
The Global In vivo CRO Market is estimated to be valued at US$ 4.70 billion in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the in vivo CRO market are IQVIA Inc., Crown Bioscience, Taconic Biosciences, Inc., PsychoGenics Inc., Evotec, Janvier Labs, Biocytogen Boston Corp, GemPharmatech, Charles River Laboratories, Icon Plc, Labcorp Drug Development, Parexel International Corporation, SMO Clinical Research (I) Pvt Ltd., WuXi AppTec, ICON plc, and Syneos Health.
In Vivo CRO Market Demand in R&D expenditure of pharmaceutical and biotechnology companies and increasing complexities in drug development provide major growth opportunities in the in vivo CRO market. CROs help sponsors reduce fixed costs and develop multi-disciplinary expertise to run preclinical studies globally.
Key players are expanding their in vivo service capabilities and global footprint through acquisitions and partnerships. For instance, Charles River acquired Citoxlab to expand toxicology services in Europe and Envigo acquired MPI Research and Anthropic to enhance its discovery and safety assessment offerings across major geographies. Market drivers A key growth driver for the in vivo CRO market is the significant investments made by pharmaceutical companies in R&D. The rising pharmaceutical R&D expenditure is necessitating outsourcing of non-core preclinical research functions to specialized CROs with expertise in various animal models and preclinical testing capabilities. As per a report, global pharma R&D spending is expected to grow at a CAGR of 4-6% between 2018-2024, thereby driving increasing demand for in vivo studies through CROs during the forecast period.
PEST Analysis
Political: Regulations pertaining to safety and ethical standards for animal and human testing impact the market. Stringent regulations increase compliance requirements and costs. Economic: In vivo CRO services experience more demand during early-phase drug development when economic conditions are favorable for R&D spending. Recessions negatively impact the market.
Social: Rising social and ethical concerns regarding animal testing put pressure on companies to minimize animal usage and cause some to shift to alternative approaches when possible. Technological: Advancements in microdosing, tissue engineering and organ-on-chip models present opportunities to supplement and potentially reduce traditional animal studies. Virtual modeling and simulation also facilitate early decision-making.
The market is concentrated in North America and Western Europe due to their large pharmaceutical R&D presence and strict regulatory systems for drug approval. North America leads in terms of value share given the large biopharma industry in the US. The Asia Pacific region is poised for the fastest growth over the forecast period. A growing biopharma industry, improved regulatory guidelines, and increasing investment in R&D particularly by Chinese and Indian firms are driving the market. Greater availability of experienced CRO partners is also encouraging more sponsors to outsource early-stage in vivo work to the Asia Pacific region.
Get This Report in Japanese Language:
Get This Report in Korean Language:
Explore More Related Article On- Antidepressant Market
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
The report provides a detailed analysis of the In vivo CRO market, including regulatory policies, upcoming technologies, key market trends, industry drivers, challenges, and key playersâ profiles and strategies.
All industries have been severely affected by the virus, and this report assesses the market, keeping in mind the presence of the pandemic.To avail Copy of the Global In vivo CRO Sample Report, Click @ https://www.reportsanddata.com/sample-enquiry-form/1634If you are involved in the In vivo CRO industry or intend to be, then this study will provide you a comprehensive outlook.
Key players who influence the In vivo CRO market:River Laboratories, Chiltern International Ltd., Parexel International, Pharmaceutical Product Development, LLC (PPD) and PRA Health SciencesFor the purpose of the study, this Reports and Data have segmented the Global In vivo CRO Market on the basis of type, GLP type, indication and the regional outlook:Type Rodent-BasedRatsMiceOthersNon-Rodent BasedHamstersGuinea PigsOthersGLP TypeNon-GLPIn HouseOutsourcingGLP ToxicologyIn HouseOutsourcingIndication Autoimmune/Inflammatory ConditionsRheumatoid ArthritisMultiple SclerosisOsteoarthritisIrritable Bowel SyndromeOthersPain ManagementChronic PainAcute PainOncologyBlood CancerSolid TumorSyngeneic ModelPatient Derived XenograftXenograftOthersCNS conditionsEpilepsyParkinsonâs DiseaseHuntingtonâs DiseaseStrokeTraumatic Brain InjuryALSMuscle RegenerationOthersDiabetesObesityOthersBased on region, the In vivo CRO global industry is segmented into:North AmericaEuropeGermanyAsia PacificLatin AmericaMiddle East and AfricaGrab Your Report at an Impressive Discount!
Please Click Here @ https://www.reportsanddata.com/discount-enquiry-form/1634The insights that are offered by this report of the In vivo CRO market are: â Detailed Overview of Global In vivo CRO market helps deliver clients and businesses making strategies.
â SWOT Analysis of each key players mentioned along with its company profile with the help of Porterâs five forces tool mechanism to compliment the same.Key Questioned Answered mentioned in the Report - What are the products offered by the In vivo CRO industry presently?What are the different applications of the products offered in this market of In vivo CRO?Who could be claimed as the most dominant and influential players in this global industry?Which factors act as the drivers of this market, and which factors pull this industry down acting as restraints?What can be determined by the trends obtained from the evaluation of the historical data for the In vivo CRO industry?There are 15 Chapters to display the Global In vivo CRO market.
Chapter 1 About Executive Summary to describe Definition, Specifications, and Classification of In vivo CRO market, Applications [Industrial & Commercial], Market Segment by Regions; Chapter 2 analyzes the objective of the study.